These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 30786864)

  • 1. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.
    Schrauben SJ; Jepson C; Hsu JY; Wilson FP; Zhang X; Lash JP; Robinson BM; Townsend RR; Chen J; Fogelfeld L; Kao P; Landis JR; Rader DJ; Hamm LL; Anderson AH; Feldman HI
    BMC Nephrol; 2019 Feb; 20(1):60. PubMed ID: 30786864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incident Type 2 Diabetes Among Individuals With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Jepson C; Hsu JY; Fischer MJ; Kusek JW; Lash JP; Ricardo AC; Schelling JR; Feldman HI;
    Am J Kidney Dis; 2019 Jan; 73(1):72-81. PubMed ID: 30177484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ricardo AC; Anderson CA; Yang W; Zhang X; Fischer MJ; Dember LM; Fink JC; Frydrych A; Jensvold NG; Lustigova E; Nessel LC; Porter AC; Rahman M; Wright Nunes JA; Daviglus ML; Lash JP;
    Am J Kidney Dis; 2015 Mar; 65(3):412-24. PubMed ID: 25458663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in predialytic, nondiabetic, chronic kidney disease patients: A hospital-based study in Eastern Uttar Pradesh, India.
    Srivastava N; Singh RG; ; Kumar A; Singh S
    Saudi J Kidney Dis Transpl; 2017; 28(1):36-43. PubMed ID: 28098101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease.
    Navaneethan SD; Beddhu S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1260-6. PubMed ID: 19033255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between chronic kidney function and homeostasis model assessment of insulin resistance and beta cell function in Korean adults with or without type 2 diabetes mellitus.
    Kim GS; Kim SG; Kim HS; Hwang EY; Lee JH; Yoon H
    Endocr J; 2017 Dec; 64(12):1181-1190. PubMed ID: 28890482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study.
    Ma A; Liu F; Wang C; Liang K; Yan F; Hou X; Liu J; Chen L
    Int Urol Nephrol; 2018 Dec; 50(12):2239-2244. PubMed ID: 30182294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance as a predictor of cardiovascular disease in patients on peritoneal dialysis.
    Li Y; Zhang L; Gu Y; Hao C; Zhu T
    Perit Dial Int; 2013; 33(4):411-8. PubMed ID: 23455976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance in chronic kidney disease: a systematic review.
    Spoto B; Pisano A; Zoccali C
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific Trajectories of Insulin Resistance Markers and Reduced Renal Function During 18 Years of Follow-up: TLGS.
    Amouzegar A; Honarvar M; Masoumi S; Tohidi M; Mehran L; Azizi F
    J Clin Endocrinol Metab; 2023 May; 108(6):e230-e239. PubMed ID: 36546593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
    Wang CJ; Bao XR; Du GW; Wang Y; Chen K; Shen ML; Wang LZ
    Int Urol Nephrol; 2014 Aug; 46(8):1609-17. PubMed ID: 24839054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated glucose disposal rate for predicting cardiovascular events and mortality in patients with non-diabetic chronic kidney disease: a prospective cohort study.
    Peng J; Zhang Y; Zhu Y; Chen W; Chen L; Ma F; Yi B; Huang Z
    BMC Med; 2024 Sep; 22(1):411. PubMed ID: 39334214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of insulin resistance to vitamin d status in children with nondiabetic chronic kidney disease.
    Conkar S; Mir S
    Saudi J Kidney Dis Transpl; 2017; 28(5):1078-1084. PubMed ID: 28937066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cardiovascular health metrics with all-cause and cardiovascular disease mortality in chronic kidney disease: A cohort study.
    Zhang S; Xue Q; Li D; Xu Y; Zhang YB; Peng J; Wu S; He X; Yang X; Liu Y; Yan T; Wu N; Wen Y; Cravens L; Wu JH; Yang CX; Pan XF
    Nutr Metab Cardiovasc Dis; 2024 Aug; 34(8):1837-1845. PubMed ID: 38760189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
    Smeijer JD; Kohan DE; Rossing P; Correa-Rotter R; Liew A; Tang SCW; de Zeeuw D; Gansevoort RT; Ju W; Lambers Heerspink HJ
    Cardiovasc Diabetol; 2023 Sep; 22(1):251. PubMed ID: 37716952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum RBP4 and CKD: Association with insulin resistance and lipids.
    Domingos MAM; Queiroz M; Lotufo PA; Benseñor IJ; Titan SMO
    J Diabetes Complications; 2017 Jul; 31(7):1132-1138. PubMed ID: 28473187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.